Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization

Human Gene Therapy

Volumn 20, Issue 1, 2009, Pages 31-39

  Kachi, Shu ^a   Binley, Katie ^b   Yokoi, Katsutoshi ^a   Umeda, Naoyasu ^a   Akiyama, Hideo ^a   Muramatu, Daisuke ^a   Iqball, Sharifah ^b   Kan, On ^b   Naylor, Stuart ^b   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; BETA GALACTOSIDASE; ENDOSTATIN; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG MECHANISM; EQUINE INFECTIOUS ANEMIA VIRUS; FEMALE; GENE; GENE TRANSFER; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PROMOTER REGION; RETINA MACULA VITELLIFORM DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TRANSIENT TRANSFECTION; VIRAL GENE DELIVERY SYSTEM; VMD 2 GENE;

ANGIOSTATINS; ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOSTATINS; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; RETINAL PIGMENT EPITHELIUM; TREATMENT OUTCOME;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS; MURINAE; MUS;

EID: 58849087072     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.046     Document Type: Article

References (27)

1. Balaggan, K.S., Binley, K., Esapa, M., Iqball, S., Askham, Z., Kan, O., Tschernutter, M., Bainbridge, J.W.B., Naylor, S., and Ali, R.R. (2006a). Stable and efficient introcular gene transfer using pseudotyped EIAV lentiviral vectors. J. Gene Med. 8, 275-285.
2. Balaggan, K.S., Binley, K., Esapa, M., Maclaren, R.E., Iqball, S., Duran, Y., Pearson, R.A., Kan, O., Barker, S.E., Smith, A.J., Bainbridge, J.W.B., Naylor, S., and Ali, R.R. (2006b). EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. Gene Ther. 13, 1153-1165.
3. Brown, D.M., Kaiser, P.K., Michels, M., Soubrane, G., Heier, J.S., Kim, R.Y., Sy, J.P., Schneider, S., and the Anchor Study Group (2006). Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1432-1444.
4. Campochiaro, P.A., Nguyen, Q.D., Shah, S.M., Klein, M.L., Holz, E., Frank, R.N., Saperstein, D.A., Gupta, A., Stout, J.T., Macko, J., Dibartolomeo, R., and Wei, L.L. (2006). Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: Results of a phase I clinical trial. Hum. Gene Ther. 17, 167-176.
5. Esumi, N., Oshima, Y., Li, Y., Campochiaro, P.A., and Zack, D.J. (2004). Analysis of the VMD2 promoter and implication of E-Box binding factors in its regulation. J. Biol. Chem. 279, 19064-19073.
6. Gehlbach, P., Demetriades, A.M., Yamamoto, S., Deering, T., Xiao, W.H., Duh, E.J., Yang, H.S., Lai, H., Kovesdi, I., Wei, L., and Campochiaro, P.A. (2003). Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and VEGF-induced breakdown of the blood-retinal barrier. Hum. Gene Ther. 14, 129-141.
7. Igarashi, T., Miyake, K., Kato, K., Watanabe, A., Ishizaki, M., Ohara, K., and Shimada, T. (2003). Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model. Gene Ther. 10, 219-226.
8. Kachi, S., Oshima, Y., Esumi, N., Kachi, M., Rogers, B., Zack, D.J., and Campochiaro, P.A. (2005). Nonviral ocular gene transfer. Gene Ther. 12, 843-851.
9. Kachi, S., Esumi, N., Zack, D.J., and Campochiaro, P.A. (2006). Sustained expression after nonviral ocular gene transfer using mammalian promoters. Gene Ther. 13, 798-804.
10. Klein, R., Klein, B.E., and Linton, K.L. (1992). Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 99, 933-943.
11. Lai, C.-C., Wu, W.-C., Chen, S.-L., Xiao, X., Tsai, T.-C., Huan, S.-J., Chen, T.-L., Tsai, R.J.-F., and Tsao, Y.-P. (2001). Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest. Ophthalmol. Vis. Sci. 42, 2401-2407.
12. Lai, C.-M., Brankov, M., Zaknich, T., Lai, Y.K.-Y., Shen, W.-Y., Constable, I.J., Kovesdi, I., and Rakoczy, P.E. (2001). Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Hum. Gene Ther. 12, 1299-1310.
13. Marneros, A.G., She, H., Zambarakji, H., Hashizume, H., Connolly, E.J., Kim, I., Gragoudas, E.S., Miller, J.W., and Olsen, B.R. (2007). Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 21, 3809-3818.
14. Maury, W. (1998). Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5, 11-23.
15. Mazarakis, N.D., Azzouz, M., Rohll, J.B., Ellard, F.M., Wilkes, F.J., Olsen, A.L., Carter, E.E., Barber, R.D., Baban, D.F., Kingsman, S.M., Kingsman, A.J., O'Malley, K., and Mitrophanous, K.A. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transprot and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121.
16. Mori, K., Ando, A., Gehlbach, P., Nesbitt, D., Takahashi, K., Goldsteen, D., Penn, M., Chen, C.T., Melia, M., Phipps, S., Moffat, D., Brazzell, K., Liau, G., Dixon, K.H., and Campochiaro, P.A. (2001a). Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am. J. Pathol. 159, 313-320.
17. Mori, K., Duh, E., Gehlbach, P., Ando, A., Takahashi, K., Pearlman, J., Mori, K., Yang, H.S., Zack, D.J., Ettyreddy, D., Brough, D.E., Wei, L.L., and Campochiaro, P.A. (2001b). Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J. Cell. Physiol. 188, 253-263.
18. Mori, K., Gehlbach, P., Ando, A., McVey, D., Wei, L., and Campochiaro, P.A. (2001c). Regression of ocular neovascularization by increased expression of pigment epitheliumderived factor. Invest. Ophthalmol. Vis. Sci. 43, 2428-2434.
19. Mori, K., Gehlbach, P., Ando, A., Wahlin, K., Gunther, V., McVey, D., Wei, L., and Campochiaro, P.A. (2002a). Intraocular adenoviral vector-mediated gene transfer is increased in proliferative retinopathies. Invest. Ophthalmol. Vis. Sci. 43, 1610-1615.
20. Mori, K., Gehlbach, P., Yamamoto, S., Duh, E., Zack, D.J., Li, Q., Berns, K.I., Raisler, B.J., Hauswirth, W.W., and Campochiaro, P.A. (2002b). AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1994-2000.
21. Provost, N., Lemeur, G., Weber, M.L., Mendes-Madeira, A., Podevin, G., Cherel, Y., Colle, M.A., Deschamps, J.Y., Moullier, P., and Rolling, F. (2005). Biodistribution of rAAV vectors following intraocular administration: Evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol. Ther. 11, 275-283.
22. Rosenfeld, P.J., Brown, D.M., Heier, J.S., Boyer, D.S., Kaiser, P.K., Chung, C.Y., Kim, R.Y., and the Marina Study Group (2006). Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419-1431.
23. Takahashi, T., Nakamura, T., Hayashi, A., Kamei, M., Nakabayashi, M., Okada, A.A., Tomita, N., Daneda, Y., and Tano, Y. (2000). Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium. Am. J. Ophthalmol. 130, 774-781.
24. Takahashi, K., Saishin, Y., Saishin, Y., Lima Silva, R., Oshima, Y., Oshima, S., Melia, M., Paszkiet, B., Zerby, D., Kadan, M.J., Liau, G., Kaleko, M., Connelly, S., Luo, T., and Campochiaro, P.A. (2003). Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J. 17, 896-898.
25. Tobe, T., Ortega, S., Luna, J.D., Ozaki, H., Okamoto, N., Derevjanik, N.L., Vinores, S.A., Basilico, C., and Campochiaro, P.A. (1998). Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 153, 1641-1646.
26. Verbeke, G., and Molenberghs, G. (2000). Linear Mixed Models for Longitudinal Data. (Springer-Verlag, New York ).
27. Wong, L.F., Azzouz, M., Walmsley, L.E., Askham, Z., Barber, R.D., Mitrophanous, K.A., Kingsman, S.M., and Mazarakis, N.D. (2004). Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol. Ther. 9, 101-111.